Literature DB >> 17466116

Antibiotic survey of Lactococcus lactis strains to six antibiotics by Etest, and establishment of new susceptibility-resistance cut-off values.

Ana Belén Flórez1, Morten Danielsen, Jenni Korhonen, Joanna Zycka, Atte von Wright, Jacek Bardowski, Baltasar Mayo.   

Abstract

In order to establish cut-off values for Lactococcus lactis to six antibiotics to distinguish susceptible and intrinsically resistant strains from those having acquired resistances, the minimum inhibitory concentration (MIC) of tetracycline, erythromycin, clindamycin, streptomycin, chloramphenicol and vancomycin was determined in 93 different Lc. lactis strains using the Etest. These bacterial strains were originally isolated from dairy and animal sources in widely separated geographical locations. Cut-offs were defined on the basis of the distribution of the MICs frequency of the studied antibiotics, which in the absence of acquired determinants should approach to a normal statistical distribution. In general, the new cut-off values proposed in this study are higher than previously defined (European Commission, 2005. The EFSA Journal 223, 1-12). Based on these new values, all the strains tested were susceptible to erythromycin, chloramphenicol and vancomycin, and 79 susceptible to all six antibiotics. However, 11 strains (around 12%) were considered resistant to tetracycline (six of which had been identified after screening of a large collection of lactococci strains for tetracycline resistance) and five (5.4%) resistant to streptomycin. Of these, two fish isolates proved to be resistance to both tetracycline and streptomycin. From the tetracycline resistant strains, tet(M) and mosaic tet(L/S) genes were amplified by PCR, demonstrating they harboured acquired antibiotic resistance determinants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466116     DOI: 10.1017/S0022029907002543

Source DB:  PubMed          Journal:  J Dairy Res        ISSN: 0022-0299            Impact factor:   1.904


  5 in total

1.  Intra- and interlaboratory performances of two commercial antimicrobial susceptibility testing methods for bifidobacteria and nonenterococcal lactic acid bacteria.

Authors:  Geert Huys; Klaas D'Haene; Margo Cnockaert; Lorenzo Tosi; Morten Danielsen; Ana Belén Flórez; Jaana Mättö; Lars Axelsson; Jenni Korhonen; Sigrid Mayrhofer; Maria Egervärn; Mauro Giacomini; Peter Vandamme
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

2.  Bacteriocin-Producing Lactic Acid Bacteria Isolated from Mangrove Forests in Southern Thailand as Potential Bio-Control Agents: Purification and Characterization of Bacteriocin Produced by Lactococcus lactis subsp. lactis KT2W2L.

Authors:  Noraphat Hwanhlem; Vanessa Biscola; Shady El-Ghaish; Emmanuel Jaffrès; Xavier Dousset; Thomas Haertlé; Aran H-Kittikun; Jean-Marc Chobert
Journal:  Probiotics Antimicrob Proteins       Date:  2013-12       Impact factor: 4.609

3.  Intra- and interspecies conjugal transfer of Tn916-like elements from Lactococcus lactis in vitro and in vivo.

Authors:  Joanna Boguslawska; Joanna Zycka-Krzesinska; Andrea Wilcks; Jacek Bardowski
Journal:  Appl Environ Microbiol       Date:  2009-08-07       Impact factor: 4.792

4.  In Vitro Evaluation of Potential Probiotic Strain Lactococcus lactis Gh1 and Its Bacteriocin-Like Inhibitory Substances for Potential Use in the Food Industry.

Authors:  Roslina Jawan; Sahar Abbasiliasi; Shuhaimi Mustafa; Mohammad Rizal Kapri; Murni Halim; Arbakariya B Ariff
Journal:  Probiotics Antimicrob Proteins       Date:  2021-04       Impact factor: 4.609

5.  Competitive Exclusion Bacterial Culture Derived from the Gut Microbiome of Nile Tilapia (Oreochromis niloticus) as a Resource to Efficiently Recover Probiotic Strains: Taxonomic, Genomic, and Functional Proof of Concept.

Authors:  Javier Fernando Melo-Bolívar; Ruth Yolanda Ruiz Pardo; Howard Junca; Hanna Evelina Sidjabat; Juan Andrés Cano-Lozano; Luisa Marcela Villamil Díaz
Journal:  Microorganisms       Date:  2022-07-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.